Liver Cancer Diagnostics Market
Liver Cancer Diagnostics Market by Test Type (AFP Tests for Liver Cancer Diagnostics, LFTs for Liver Cancer Diagnostics, Biopsy for Liver Cancer Diagnostics) By End User (Hospital-associated Labs, Independent Diagnostic Laboratories, Cancer Research Institutes), by Region- 2022 to 2032
Analysis of Liver Cancer Diagnostics market covering 30 + countries including analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Liver Cancer Diagnostics Market Outlook (2022-2032)
The global liver cancer diagnostics market reached a valuation of around US$ 11.73 Bn in 2022 and is slated to accelerate at a CAGR of 8.2% to top US$ 26 Bn by 2032. This noteworthy jump in market size is because of growing investments in research programs in regions like North America & Europe.
North America accounts for a governing market share of around 35% of the global market, primarily due to the increasing prevalence of cancer, which can be linked to the rising healthcare expenditure in the region.
Report Attributes |
Details |
|---|---|
|
Liver Cancer Diagnostics Market Size (2022) |
US$ 11.73 Billion |
|
Projected Market Value (2032F) |
US$ 26 Billion |
|
Global Market Growth Rate (2022-2032) |
8.2% CAGR |
|
North America Pacific Market Share (2022) |
35% |
|
Europe Market Share (2022) |
27% |
|
Market Share of Cancer Research Institutes (2022) |
40% |
|
Key Companies Profiled |
|
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
Liver Cancer Diagnostics Demand Analysis (2017-2021) in Comparison to Market Estimations (2022-2032)
Instances of cancer have seen a substantial rise over the past decade, and this rise is expected to be seen through this decade as well. Liver cancer cases have seen a gradual increase as the lifestyle of people has changed drastically over the years. The prevalence of obesity due to poor eating habits is one of the major factors responsible for the increase in liver cancer across the world.
Rising consumption of tobacco and alcohol is also a major lifestyle change that has promoted the disease, in turn, giving rise to more demand for effective liver cancer diagnostics. Hepatocellular carcinoma (HCC) diagnostics and liver carcinoma diagnostics are two major diagnostic methods that are in demand and expected to be prominent over the decade. Demand for liver cancer diagnostics is anticipated to rise at a robust CAGR of 8.2% over the 2022 to 2032 forecast period.
What Role Does Imaging Play in Liver Cancer Diagnostics?
Recent Developments in Imaging Technology Expands the Market Growth for Liver Cancer Diagnostics
Imaging plays a vital role in cancer diagnosis, as it allows medical professionals to explore the extent of tumors and their nature. Imaging for liver cancer diagnostics is also a very popular diagnostic method, and there is a wide array of imaging technologies and techniques to choose from. According to the latest report published by Fact.MR, Scientists are developing new kinds of imaging tests that may be better at detecting small tumors.
For example, one group of TLC-funded researchers is using small molecules, called peptides, which attach to liver cancer cells. These peptides are linked to dyes that can be seen with a CT scan or MRI. Some of the imaging technologies and techniques are:
- Endoscopy for Liver Cancer Diagnostics
- Computed Tomography (CT) Scan for Liver Cancer Diagnostics
- Magnetic Resonance Imaging (MRI) Scan for Liver Cancer Diagnostics
- Ultrasound Imaging for Liver Cancer Diagnostics
- MRI Imaging Tests for Liver Cancer Diagnostics
- Laparoscopy Tests for Liver Cancer Diagnostics
Demand for imaging in liver cancer diagnostics is anticipated to be significant as imaging technology advances and becomes more accurate, efficient, and affordable. While there are some concerns regarding the constant use of imaging on the body, these constraints are expected to be ironed out as technology advances and research increases.
Demand for computed tomography (CT) scans in liver cancer diagnostics, demand for magnetic resonance imaging (MRI) scans in liver cancer diagnostics, demand for X-rays in liver cancer diagnostics, and demand for ultrasound imaging in liver cancer diagnostics are all expected to see similar growth as their adoption in various diagnostic procedures is developed.
An increase in demand for liver cancer diagnostic procedures is also expected to drive demand for endoscopy in liver cancer diagnostics and demand for laparoscopy tests in liver cancer diagnostics as their application scope increases.
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
Why is Demand for Laboratory Tests in Liver Cancer Diagnostics High?
Rising Laboratory Tests to Develop Novel Treatments are Likely to Fuel Market Growth
Laboratory tests for liver cancer diagnostics are many to choose from, and all of them indicate different aspects of cancer tumors. Lab tests aid in understanding and determining the causes and nature of cancer, and can be crucial in planning an effective treatment plan.
Blood tests for liver cancer diagnostics are the most common lab-based tests. Demand for AFP tests for liver cancer diagnostics is moderate, as these tests are most effective in determining the treatment for the disease. Demand for LFTs for liver cancer diagnostics is slightly higher than that of AFP tests, as they provide direct information on the condition of the liver.
Research is bolstering and pioneering new tests that make diagnosis more efficient, accurate, and affordable. The use of growth factors and receptors for liver cancer diagnostics, enzymes and isoenzymes biomarkers for liver cancer diagnostics, and molecular markers for liver cancer diagnostics are some major areas of research that show promise shortly. As research progresses, we are expected to see a rise in the application of these new methods and tests.
How Crucial is Development in the Liver Cancer Diagnostics Market for Start-ups?
New Entrants are Developing Advanced Devices for Early Detection of Liver Cancer
In recent years, there have been several advances in treating liver cancer. While removing liver cancer through surgery can be an effective form of liver cancer treatment for some patients, it’s not suitable for all patients. As researchers continue to uncover new and innovative treatments, doctors have more options to consider for their patients. To gain a competitive edge, the new players are investing in the technologies to develop new tests for the early detection of diagnosed liver cancer.
- Founded in 2000, Helio is a developer of AI-based diagnostic tests for the early detection of cancer. The company uses artificial intelligence and machine learning to identify unique and proprietary DNA signatures and develops multi-analyte blood tests. The company's flagship product is the HelioLiver test for the early detection of liver cancer. According to NIH, Liver cancer that is diagnosed at an early stage has a good chance of being cured with surgery, surgery plus liver transplantation, or treatments such as radiofrequency ablation. Start-ups are working to develop tests that better detect early-stage liver cancer. They are also trying to figure out who is most at risk for liver cancer and most likely to benefit from these tests.
- Established in 2021, Echoliv is an AI-based liver cancer diagnosis tool for providers. The company has developed software that assists radiologists and hepatologists with disease diagnoses. It has features for early detection of cancer, report writing, and telecommunication. data analysis and more.
Which Regions Have Bright Investment Scope for Liver Cancer Diagnostics Suppliers?
In terms of Revenue, North America is projected to capture the Governing Share in the Market
This research details the global liver cancer diagnostics landscape across regions such as North America, Latin America, Europe, APAC, and MEA. North America is anticipated to dominate the market with around 35% global liver cancer diagnostics market share. According to the American Cancer Society, in the past few decades, the incidence rates of liver cancer have more than tripled and the death rates have more than doubled during this time. As per the same source, in 2021, around 42,230 new cases of liver cancer are expected to be diagnosed in the U.S., which will lead to around 30,230 deaths.
Demand in Europe is predicted to rise at a steady pace over the decade. Both these regions will see high growth owing to the rising adoption of advanced technology and increasing instances of liver cancer. In 2021, 2.7 million people in the European Union were diagnosed with the disease, and another 1.3 million people lost their lives to it.
The APAC region is anticipated to experience the highest CAGR owing to the adoption of improved diagnostic procedures for liver carcinoma in countries such as India and China. Demand for liver cancer diagnostics in independent diagnostic laboratories in APAC is expected to see a major rise as the cost-effectiveness of diagnostic solutions increases. The MEA market is expected to witness steady growth in demand for liver cancer diagnostics.
Country-wise Analysis
What Makes the U.S. Liver Cancer Diagnostics Market a Hotspot?
Recent FDA Approvals of Novel Technologies Have Augmented the Market Development for Liver Cancer Diagnostics
The U.S. is a highly lucrative market for liver cancer diagnostics, and this can be associated with factors such as the presence of prominent providers, rising prevalence of related diseases, early adoption of novel procedures, etc. Demand for liver cancer diagnostics in cancer research institutes is expected to see a rise as research in the nation picks up pace.
In June 2020, the Food and Drug Administration (FDA) approved atezolizumab (Tecentriq) and bevacizumab (Avastin) as an initial treatment for people with liver cancer that has spread or that can’t be treated with surgery. This new treatment appears to be better than standard therapy for people with a type of liver cancer called hepatocellular carcinoma (HCC).
What is the Outlook for Manufacturers of Liver Cancer Diagnosis Instruments in China?
Soaring Investments in Cancer Research & Favorable Government Initiatives are Likely to Rev up Regional Sales
China is the second-largest economy in the world, and that makes it a huge market for almost everything. The nation has a rising medical tourism industry that is propelling demand for liver cancer diagnostics as well.
Sales of liver cancer diagnosis instruments are also expected to see a rise as the government is backing manufacturers with favorable funding initiatives. Manufacturers of liver cancer diagnostic instruments in China are also investing in the research & development of cost-effective solutions to boost their sales.
In August 2020, Berry Oncology launched a liver cancer early screening product, named “Lai Si Ning.” Based on the Whole-Genome Sequencing Technology of cfDNA, the liquid biopsy can achieve a 95.42 percent sensitivity while maintaining the specificity of 97.91 percent. (To compare, the sensitivity of early liver cancer detection using traditional serum markers and imaging is only 63 percent.)
Category-wise Analysis
Why is Demand for Liver Cancer Diagnostics in Hospital-associated Labs Prominent?
Hospital-associated labs are expected to account for a majority of the revenue share in the global liver cancer diagnostics industry over the forecast period.
Increasing focus on procedures that require medical surroundings and tests that require hospitalization, and increasing demand for biopsy for liver cancer diagnostics are some of the major factors that are propelling the growth of hospital-associated labs in the market.
Competitive Landscape
Top manufacturers of liver cancer diagnosis instruments are investing in research & development that would aid in diagnosis and treatment more effectively and efficiently.
- In August 2021, Illumina, Inc. announced the acquisition of GRAIL, a healthcare company focused on life-saving early detection of multiple cancers but will hold GRAIL as a separate company during the European Commission's ongoing regulatory review.
- In September 2021, India-based BDR Pharma announced the launch of the generic cancer drug called Cabozantinib. The drug is said to be helpful in the treatment of hepatocellular carcinoma and other types of cancers.
- In June 2022, Adaptimmune and Genetech announced a collaboration through which they would be commercializing allogeneic T-cell therapies to treat various cancers. This collaboration could generate around US$ 3 Bn for the companies involved.
- In August 2021, 111, a digital health platform, entered into a strategic cooperation agreement with Suzhou Zelgen Biopharmaceuticals Co. to develop a virtual platform for liver cancer-affected individuals. The platform would provide patients access to online doctor consultations and medicines.
Key Segments in Liver Cancer Diagnostics Industry Research
-
By Test Type :
- AFP Tests
- LFTs
- Biopsy
- Others
-
By End User :
- Hospital-associated Labs
- Independent Diagnostic Laboratories
- Cancer Research Institutes
- Others
-
By Region :
- North America
- Europe
- Asia Pacific
- The Middle East & Africa
- Latin America
Table of Content
1. Global Liver Cancer Diagnostics Market - Executive Summary 2. Global Liver Cancer Diagnostics Market Overview 2.1. Introduction 2.1.1. Global Liver Cancer Diagnostics Market Taxonomy 2.1.2. Global Liver Cancer Diagnostics Market Definition 2.2. Global Liver Cancer Diagnostics Market Size (US$ Mn) and Forecast, 2017-2021 2.2.1. Global Liver Cancer Diagnostics Market Y-o-Y Growth 2.3. Global Liver Cancer Diagnostics Market Dynamics 2.3.1. Drivers 2.3.2. Restraints 2.3.3. Trends 2.4. Supply Chain 2.5. Epidemiology 2.6. List of Distributors 2.7. Average Pricing Analysis 2.8. Regulations 2.9. Key Participants Market Presence (Intensity Map) By Region 3. Global Liver Cancer Diagnostics Market Analysis and Forecast By Test Type 3.1. Global Liver Cancer Diagnostics Market Size and Forecast By Test Type, 2017-2021 3.1.1. AFP Tests Liver Cancer Diagnostics Market Size and Forecast, 2017-2021 3.1.1.1. Revenue (US$ Mn) Comparison, By Region 3.1.1.2. Market Share Comparison, By Region 3.1.1.3. Y-o-Y growth Comparison, By Region 3.1.2. LFTs Liver Cancer Diagnostics Market Size and Forecast, 2017-2021 3.1.2.1. Revenue (US$ Mn) Comparison, By Region 3.1.2.2. Market Share Comparison, By Region 3.1.2.3. Y-o-Y growth Comparison, By Region 3.1.3. Biopsy Liver Cancer Diagnostics Market Size and Forecast, 2017-2021 3.1.3.1. Revenue (US$ Mn) Comparison, By Region 3.1.3.2. Market Share Comparison, By Region 3.1.3.3. Y-o-Y growth Comparison, By Region 3.1.4. Other Liver Cancer Diagnostics Market Size and Forecast, 2017-2021 3.1.4.1. Revenue (US$ Mn) Comparison, By Region 3.1.4.2. Market Share Comparison, By Region 3.1.4.3. Y-o-Y growth Comparison, By Region 4. Global Liver Cancer Diagnostics Market Analysis and Forecast By End User 4.1. Global Liver Cancer Diagnostics Market Size and Forecast By End User, 2017-2021 4.1.1. Hospital Associated Labs Liver Cancer Diagnostics Market Size and Forecast, 2017-2021 4.1.1.1. Revenue (US$ Mn) Comparison, By Region 4.1.1.2. Market Share Comparison, By Region 4.1.1.3. Y-o-Y growth Comparison, By Region 4.1.2. Independent Diagnostic Laboratories Liver Cancer Diagnostics Market Size and Forecast, 2017-2021 4.1.2.1. Revenue (US$ Mn) Comparison, By Region 4.1.2.2. Market Share Comparison, By Region 4.1.2.3. Y-o-Y growth Comparison, By Region 4.1.3. Cancer Research Institutes Liver Cancer Diagnostics Market Size and Forecast, 2017-2021 4.1.3.1. Revenue (US$ Mn) Comparison, By Region 4.1.3.2. Market Share Comparison, By Region 4.1.3.3. Y-o-Y growth Comparison, By Region 4.1.4. Others Liver Cancer Diagnostics Market Size and Forecast, 2017-2021 4.1.4.1. Revenue (US$ Mn) Comparison, By Region 4.1.4.2. Market Share Comparison, By Region 4.1.4.3. Y-o-Y growth Comparison, By Region 5. Global Liver Cancer Diagnostics Market Analysis and Forecast By Region 5.1. Global Liver Cancer Diagnostics Market Size and Forecast, 2017-2021 5.1.1. North America Liver Cancer Diagnostics Market Size and Forecast, 2017-2021 5.1.1.1. Revenue (US$ Mn) Comparison, By Test Type 5.1.1.2. Revenue (US$ Mn) Comparison, By End User 5.1.2. Latin America Liver Cancer Diagnostics Market Size and Forecast, 2017-2021 5.1.2.1. Revenue (US$ Mn) Comparison, By Test Type 5.1.2.2. Revenue (US$ Mn) Comparison, By End User 5.1.3. Europe Liver Cancer Diagnostics Market Size and Forecast, 2017-2021 5.1.3.1. Revenue (US$ Mn) Comparison, By Test Type 5.1.3.2. Revenue (US$ Mn) Comparison, By End User 5.1.4. Japan Liver Cancer Diagnostics Market Size and Forecast, 2017-2021 5.1.4.1. Revenue (US$ Mn) Comparison, By Test Type 5.1.4.2. Revenue (US$ Mn) Comparison, By End User 5.1.5. APEJ Liver Cancer Diagnostics Market Size and Forecast, 2017-2021 5.1.5.1. Revenue (US$ Mn) Comparison, By Test Type 5.1.5.2. Revenue (US$ Mn) Comparison, By End User 5.1.6. MEA Liver Cancer Diagnostics Market Size and Forecast, 2017-2021 5.1.6.1. Revenue (US$ Mn) Comparison, By Test Type 5.1.6.2. Revenue (US$ Mn) Comparison, By End User 6. North America Liver Cancer Diagnostics Market Analysis and Forecast, By Country, 2017-2021 6.1. US Liver Cancer Diagnostics Market Size and Forecast, 2017-2021 6.1.1. Revenue (US$ Mn) Comparison, By Test Type 6.1.2. Revenue (US$ Mn) Comparison, By End User 6.2. Canada Liver Cancer Diagnostics Market Size and Forecast, 2017-2021 6.2.1. Revenue (US$ Mn) Comparison, By Test Type 6.2.2. Revenue (US$ Mn) Comparison, By End User 7. Latin America Liver Cancer Diagnostics Market Analysis and Forecast, By Country, 2017-2021 7.1. Brazil Liver Cancer Diagnostics Market Size and Forecast, 2017-2021 7.1.1. Revenue (US$ Mn) Comparison, By Test Type 7.1.2. Revenue (US$ Mn) Comparison, By End User 7.2. Mexico Liver Cancer Diagnostics Market Size and Forecast, 2017-2021 7.2.1. Revenue (US$ Mn) Comparison, By Test Type 7.2.2. Revenue (US$ Mn) Comparison, By End User 7.3. Argentina Liver Cancer Diagnostics Market Size and Forecast, 2017-2021 7.3.1. Revenue (US$ Mn) Comparison, By Test Type 7.3.2. Revenue (US$ Mn) Comparison, By End User 8. Europe Liver Cancer Diagnostics Market Analysis and Forecast, By Country, 2017-2021 8.1. Germany Liver Cancer Diagnostics Market Size and Forecast, 2017-2021 8.1.1. Revenue (US$ Mn) Comparison, By Test Type 8.1.2. Revenue (US$ Mn) Comparison, By End User 8.2. UK Liver Cancer Diagnostics Market Size and Forecast, 2017-2021 8.2.1. Revenue (US$ Mn) Comparison, By Test Type 8.2.2. Revenue (US$ Mn) Comparison, By End User 8.3. France Liver Cancer Diagnostics Market Size and Forecast, 2017-2021 8.3.1. Revenue (US$ Mn) Comparison, By Test Type 8.3.2. Revenue (US$ Mn) Comparison, By End User 8.4. Spain Liver Cancer Diagnostics Market Size and Forecast, 2017-2021 8.4.1. Revenue (US$ Mn) Comparison, By Test Type 8.4.2. Revenue (US$ Mn) Comparison, By End User 8.5. Italy Liver Cancer Diagnostics Market Size and Forecast, 2017-2021 8.5.1. Revenue (US$ Mn) Comparison, By Test Type 8.5.2. Revenue (US$ Mn) Comparison, By End User 8.6. Nordic Liver Cancer Diagnostics Market Size and Forecast, 2017-2021 8.6.1. Revenue (US$ Mn) Comparison, By Test Type 8.6.2. Revenue (US$ Mn) Comparison, By End User 9. Japan Liver Cancer Diagnostics Market Analysis and Forecast, By Country, 2017-2021 9.1. Japan Liver Cancer Diagnostics Market Size and Forecast, 2017-2021 9.1.1. Revenue (US$ Mn) Comparison, By Test Type 9.1.2. Revenue (US$ Mn) Comparison, By End User 10. APEJ Liver Cancer Diagnostics Market Analysis and Forecast, By Country, 2017-2021 10.1. China Liver Cancer Diagnostics Market Size and Forecast, 2017-2021 10.1.1. Revenue (US$ Mn) Comparison, By Test Type 10.1.2. Revenue (US$ Mn) Comparison, By End User 10.2. India Liver Cancer Diagnostics Market Size and Forecast, 2017-2021 10.2.1. Revenue (US$ Mn) Comparison, By Test Type 10.2.2. Revenue (US$ Mn) Comparison, By End User 10.3. Malaysia Liver Cancer Diagnostics Market Size and Forecast, 2017-2021 10.3.1. Revenue (US$ Mn) Comparison, By Test Type 10.3.2. Revenue (US$ Mn) Comparison, By End User 10.4. Thailand Liver Cancer Diagnostics Market Size and Forecast, 2017-2021 10.4.1. Revenue (US$ Mn) Comparison, By Test Type 10.4.2. Revenue (US$ Mn) Comparison, By End User 10.5. Singapore Liver Cancer Diagnostics Market Size and Forecast, 2017-2021 10.5.1. Revenue (US$ Mn) Comparison, By Test Type 10.5.2. Revenue (US$ Mn) Comparison, By End User 10.6. Australia Liver Cancer Diagnostics Market Size and Forecast, 2017-2021 10.6.1. Revenue (US$ Mn) Comparison, By Test Type 10.6.2. Revenue (US$ Mn) Comparison, By End User 11. MEA Liver Cancer Diagnostics Market Analysis and Forecast, By Country, 2017-2021 11.1. GCC Countries Liver Cancer Diagnostics Market Size and Forecast, 2017-2021 11.1.1. Revenue (US$ Mn) Comparison, By Test Type 11.1.2. Revenue (US$ Mn) Comparison, By End User 11.2. South Africa Liver Cancer Diagnostics Market Size and Forecast, 2017-2021 11.2.1. Revenue (US$ Mn) Comparison, By Test Type 11.2.2. Revenue (US$ Mn) Comparison, By End User 11.3. Nigeria Liver Cancer Diagnostics Market Size and Forecast, 2017-2021 11.3.1. Revenue (US$ Mn) Comparison, By Test Type 11.3.2. Revenue (US$ Mn) Comparison, By End User 11.4. Israel Liver Cancer Diagnostics Market Size and Forecast, 2017-2021 11.4.1. Revenue (US$ Mn) Comparison, By Test Type 11.4.2. Revenue (US$ Mn) Comparison, By End User 12. Global Liver Cancer Diagnostics Market Company/Manufactures/Distributors/Suppliers Profile and Revenue Projections 12.1. Company Share Analysis By Region 12.1.1. Abbott Laboratories 12.1.1.1. Company Overview 12.1.1.2. Liver Cancer Diagnostics Market Test Type list 12.1.1.3. Liver Cancer Diagnostics Market Test Type Sales Data and Key Financials 12.1.1.4. Key Developments 12.1.1.5. SWOT Analysis 12.1.2. Agilent Technologies, Inc. 12.1.2.1. Company Overview 12.1.2.2. Liver Cancer Diagnostics Market Test Type list 12.1.2.3. Liver Cancer Diagnostics Market Test Type Sales Data and Key Financials 12.1.2.4. Key Developments 12.1.2.5. SWOT Analysis 12.1.3. Bio Rad Laboratories Inc. 12.1.3.1. Company Overview 12.1.3.2. Liver Cancer Diagnostics Market Test Type list 12.1.3.3. Liver Cancer Diagnostics Market Test Type Sales Data and Key Financials 12.1.3.4. Key Developments 12.1.3.5. SWOT Analysis 12.1.4. F. Hoffmann-La Roche Ltd. 12.1.4.1. Company Overview 12.1.4.2. Liver Cancer Diagnostics Market Test Type list 12.1.4.3. Liver Cancer Diagnostics Market Test Type Sales Data and Key Financials 12.1.4.4. Key Developments 12.1.4.5. SWOT Analysis 12.1.5. Thermo Fisher Scientific Inc. 12.1.5.1. Company Overview 12.1.5.2. Liver Cancer Diagnostics Market Test Type list 12.1.5.3. Liver Cancer Diagnostics Market Test Type Sales Data and Key Financials 12.1.5.4. Key Developments 12.1.5.5. SWOT Analysis 12.1.6. Magna International Inc. 12.1.6.1. Company Overview 12.1.6.2. Liver Cancer Diagnostics Market Test Type list 12.1.6.3. Liver Cancer Diagnostics Market Test Type Sales Data and Key Financials 12.1.6.4. Key Developments 12.1.6.5. SWOT Analysis 12.1.7. Hyundai Mobis 12.1.7.1. Company Overview 12.1.7.2. Liver Cancer Diagnostics Market Test Type list 12.1.7.3. Liver Cancer Diagnostics Market Test Type Sales Data and Key Financials 12.1.7.4. Key Developments 12.1.7.5. SWOT Analysis 12.1.8. Plastic Omnium Group 12.1.8.1. Company Overview 12.1.8.2. Liver Cancer Diagnostics Market Test Type list 12.1.8.3. Liver Cancer Diagnostics Market Test Type Sales Data and Key Financials 12.1.8.4. Key Developments 12.1.8.5. SWOT Analysis 12.1.9. Samvardhana Motherson Automotive Systems Group 12.1.9.1. Company Overview 12.1.9.2. Liver Cancer Diagnostics Market Test Type list 12.1.9.3. Liver Cancer Diagnostics Market Test Type Sales Data and Key Financials 12.1.9.4. Key Developments 12.1.9.5. SWOT Analysis 12.1.10. SL Corporation 12.1.10.1. Company Overview 12.1.10.2. Liver Cancer Diagnostics Market Test Type list 12.1.10.3. Liver Cancer Diagnostics Market Test Type Sales Data and Key Financials 12.1.10.4. Key Developments 12.1.10.5. SWOT Analysis 12.1.11. Valeo S.A. 12.1.11.1. Company Overview 12.1.11.2. Liver Cancer Diagnostics Market Test Type list 12.1.11.3. Liver Cancer Diagnostics Market Test Type Sales Data and Key Financials 12.1.11.4. Key Developments 12.1.11.5. SWOT Analysis 12.1.12. Montaplast GmbH 12.1.12.1. Company Overview 12.1.12.2. Liver Cancer Diagnostics Market Test Type list 12.1.12.3. Liver Cancer Diagnostics Market Test Type Sales Data and Key Financials 12.1.12.4. Key Developments 12.1.12.5. SWOT Analysis 13. Research Methodology 14. Secondary and Primary Sources 15. Assumptions and Acronyms 16. Disclaimer
Don't Need a Global Report?
save 40%! on Country & Region specific reports
List Of Table
TABLE 01: Global Liver Cancer Diagnostics Market Value (US$ Mn), 2016-2020
TABLE 02: Global Liver Cancer Diagnostics Market Value (US$ Mn), 2022-2032
TABLE 03: Global Liver Cancer Diagnostics Market Value (US$ Mn) and Y-o-Y, 2017-2021
TABLE 04: Global AFP Tests Segment Value (US$ Mn), By Region 2016-2020
TABLE 05: Global AFP Tests Segment Value (US$ Mn), By Region 2022-2032
TABLE 06: Global AFP Tests Segment Market Share, By Region 2016-2020
TABLE 07: Global AFP Tests Segment Market Share, By Region 2022-2032
TABLE 08: Global AFP Tests Segment Y-o-Y, By Region 2017-2021
TABLE 09: Global LFTs Segment Value (US$ Mn), By Region 2016-2020
TABLE 10: Global LFTs Segment Value (US$ Mn), By Region 2022-2032
TABLE 11: Global LFTs Segment Market Share, By Region 2016-2020
TABLE 12: Global LFTs Segment Market Share, By Region 2022-2032
TABLE 13: Global LFTs Segment Y-o-Y, By Region 2017-2021
TABLE 14: Global Biopsy Segment Value (US$ Mn), By Region 2016-2020
TABLE 15: Global Biopsy Segment Value (US$ Mn), By Region 2022-2032
TABLE 16: Global Biopsy Segment Market Share, By Region 2016-2020
TABLE 17: Global Biopsy Segment Market Share, By Region 2022-2032
TABLE 18: Global Biopsy Segment Y-o-Y, By Region 2017-2021
TABLE 19: Global Other Segment Value (US$ Mn), By Region 2016-2020
TABLE 20: Global Other Segment Value (US$ Mn), By Region 2022-2032
TABLE 21: Global Other Segment Market Share, By Region 2016-2020
TABLE 22: Global Other Segment Market Share, By Region 2022-2032
TABLE 23: Global Other Segment Y-o-Y, By Region 2017-2021
TABLE 24: Global Hospital Associated Labs Segment Value (US$ Mn), By Region 2016-2020
TABLE 25: Global Hospital Associated Labs Segment Value (US$ Mn), By Region 2022-2032
TABLE 26: Global Hospital Associated Labs Segment Market Share, By Region 2016-2020
TABLE 27: Global Hospital Associated Labs Segment Market Share, By Region 2022-2032
TABLE 28: Global Hospital Associated Labs Segment Y-o-Y, By Region 2017-2021
TABLE 29: Global Independent Diagnostic Laboratories Segment Value (US$ Mn), By Region 2016-2020
TABLE 30: Global Independent Diagnostic Laboratories Segment Value (US$ Mn), By Region 2022-2032
TABLE 31: Global Independent Diagnostic Laboratories Segment Market Share, By Region 2016-2020
TABLE 32: Global Independent Diagnostic Laboratories Segment Market Share, By Region 2022-2032
TABLE 33: Global Independent Diagnostic Laboratories Segment Y-o-Y, By Region 2017-2021
TABLE 34: Global Cancer Research Institutes Segment Value (US$ Mn), By Region 2016-2020
TABLE 35: Global Cancer Research Institutes Segment Value (US$ Mn), By Region 2022-2032
TABLE 36: Global Cancer Research Institutes Segment Market Share, By Region 2016-2020
TABLE 37: Global Cancer Research Institutes Segment Market Share, By Region 2022-2032
TABLE 38: Global Cancer Research Institutes Segment Y-o-Y, By Region 2017-2021
TABLE 39: Global Others Segment Value (US$ Mn), By Region 2016-2020
TABLE 40: Global Others Segment Value (US$ Mn), By Region 2022-2032
TABLE 41: Global Others Segment Market Share, By Region 2016-2020
TABLE 42: Global Others Segment Market Share, By Region 2022-2032
TABLE 43: Global Others Segment Y-o-Y, By Region 2017-2021
TABLE 44: North America Liver Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020
TABLE 45: North America Liver Cancer Diagnostics Market Value (US$ Mn), By Test Type 2022-2032
TABLE 46: North America Liver Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020
TABLE 47: North America Liver Cancer Diagnostics Market Value (US$ Mn), By End User 2022-2032
TABLE 48: Latin America Liver Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020
TABLE 49: Latin America Liver Cancer Diagnostics Market Value (US$ Mn), By Test Type 2022-2032
TABLE 50: Latin America Liver Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020
TABLE 51: Latin America Liver Cancer Diagnostics Market Value (US$ Mn), By End User 2022-2032
TABLE 52: Europe Liver Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020
TABLE 53: Europe Liver Cancer Diagnostics Market Value (US$ Mn), By Test Type 2022-2032
TABLE 54: Europe Liver Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020
TABLE 55: Europe Liver Cancer Diagnostics Market Value (US$ Mn), By End User 2022-2032
TABLE 56: Japan Liver Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020
TABLE 57: Japan Liver Cancer Diagnostics Market Value (US$ Mn), By Test Type 2022-2032
TABLE 58: Japan Liver Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020
TABLE 59: Japan Liver Cancer Diagnostics Market Value (US$ Mn), By End User 2022-2032
TABLE 60: APEJ Liver Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020
TABLE 61: APEJ Liver Cancer Diagnostics Market Value (US$ Mn), By Test Type 2022-2032
TABLE 62: APEJ Liver Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020
TABLE 63: APEJ Liver Cancer Diagnostics Market Value (US$ Mn), By End User 2022-2032
TABLE 64: MEA Liver Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020
TABLE 65: MEA Liver Cancer Diagnostics Market Value (US$ Mn), By Test Type 2022-2032
TABLE 66: MEA Liver Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020
TABLE 67: MEA Liver Cancer Diagnostics Market Value (US$ Mn), By End User 2022-2032
TABLE 68: US Liver Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020
TABLE 69: US Liver Cancer Diagnostics Market Value (US$ Mn), By Test Type 2022-2032
TABLE 70: US Liver Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020
TABLE 71: US Liver Cancer Diagnostics Market Value (US$ Mn), By End User 2022-2032
TABLE 72: Canada Liver Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020
TABLE 73: Canada Liver Cancer Diagnostics Market Value (US$ Mn), By Test Type 2022-2032
TABLE 74: Canada Liver Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020
TABLE 75: Canada Liver Cancer Diagnostics Market Value (US$ Mn), By End User 2022-2032
TABLE 76: Brazil Liver Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020
TABLE 77: Brazil Liver Cancer Diagnostics Market Value (US$ Mn), By Test Type 2022-2032
TABLE 78: Brazil Liver Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020
TABLE 79: Brazil Liver Cancer Diagnostics Market Value (US$ Mn), By End User 2022-2032
TABLE 80: Mexico Liver Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020
TABLE 81: Mexico Liver Cancer Diagnostics Market Value (US$ Mn), By Test Type 2022-2032
TABLE 82: Mexico Liver Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020
TABLE 83: Mexico Liver Cancer Diagnostics Market Value (US$ Mn), By End User 2022-2032
TABLE 84: Argentina Liver Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020
TABLE 85: Argentina Liver Cancer Diagnostics Market Value (US$ Mn), By Test Type 2022-2032
TABLE 86: Argentina Liver Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020
TABLE 87: Argentina Liver Cancer Diagnostics Market Value (US$ Mn), By End User 2022-2032
TABLE 88: Germany Liver Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020
TABLE 89: Germany Liver Cancer Diagnostics Market Value (US$ Mn), By Test Type 2022-2032
TABLE 90: Germany Liver Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020
TABLE 91: Germany Liver Cancer Diagnostics Market Value (US$ Mn), By End User 2022-2032
TABLE 92: UK Liver Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020
TABLE 93: UK Liver Cancer Diagnostics Market Value (US$ Mn), By Test Type 2022-2032
TABLE 94: UK Liver Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020
TABLE 95: UK Liver Cancer Diagnostics Market Value (US$ Mn), By End User 2022-2032
TABLE 96: France Liver Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020
TABLE 97: France Liver Cancer Diagnostics Market Value (US$ Mn), By Test Type 2022-2032
TABLE 98: France Liver Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020
TABLE 99: France Liver Cancer Diagnostics Market Value (US$ Mn), By End User 2022-2032
TABLE 100: Spain Liver Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020
TABLE 101: Spain Liver Cancer Diagnostics Market Value (US$ Mn), By Test Type 2022-2032
TABLE 102: Spain Liver Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020
TABLE 103: Spain Liver Cancer Diagnostics Market Value (US$ Mn), By End User 2022-2032
TABLE 104: Italy Liver Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020
TABLE 105: Italy Liver Cancer Diagnostics Market Value (US$ Mn), By Test Type 2022-2032
TABLE 106: Italy Liver Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020
TABLE 107: Italy Liver Cancer Diagnostics Market Value (US$ Mn), By End User 2022-2032
TABLE 108: Nordic Liver Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020
TABLE 109: Nordic Liver Cancer Diagnostics Market Value (US$ Mn), By Test Type 2022-2032
TABLE 110: Nordic Liver Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020
TABLE 111: Nordic Liver Cancer Diagnostics Market Value (US$ Mn), By End User 2022-2032
TABLE 112: Japan Liver Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020
TABLE 113: Japan Liver Cancer Diagnostics Market Value (US$ Mn), By Test Type 2022-2032
TABLE 114: Japan Liver Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020
TABLE 115: Japan Liver Cancer Diagnostics Market Value (US$ Mn), By End User 2022-2032
TABLE 116: China Liver Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020
TABLE 117: China Liver Cancer Diagnostics Market Value (US$ Mn), By Test Type 2022-2032
TABLE 118: China Liver Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020
TABLE 119: China Liver Cancer Diagnostics Market Value (US$ Mn), By End User 2022-2032
TABLE 120: India Liver Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020
TABLE 121: India Liver Cancer Diagnostics Market Value (US$ Mn), By Test Type 2022-2032
TABLE 122: India Liver Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020
TABLE 123: India Liver Cancer Diagnostics Market Value (US$ Mn), By End User 2022-2032
TABLE 124: Malaysia Liver Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020
TABLE 125: Malaysia Liver Cancer Diagnostics Market Value (US$ Mn), By Test Type 2022-2032
TABLE 126: Malaysia Liver Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020
TABLE 127: Malaysia Liver Cancer Diagnostics Market Value (US$ Mn), By End User 2022-2032
TABLE 128: Thailand Liver Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020
TABLE 129: Thailand Liver Cancer Diagnostics Market Value (US$ Mn), By Test Type 2022-2032
TABLE 130: Thailand Liver Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020
TABLE 131: Thailand Liver Cancer Diagnostics Market Value (US$ Mn), By End User 2022-2032
TABLE 132: Singapore Liver Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020
TABLE 133: Singapore Liver Cancer Diagnostics Market Value (US$ Mn), By Test Type 2022-2032
TABLE 134: Singapore Liver Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020
TABLE 135: Singapore Liver Cancer Diagnostics Market Value (US$ Mn), By End User 2022-2032
TABLE 136: Australia Liver Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020
TABLE 137: Australia Liver Cancer Diagnostics Market Value (US$ Mn), By Test Type 2022-2032
TABLE 138: Australia Liver Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020
TABLE 139: Australia Liver Cancer Diagnostics Market Value (US$ Mn), By End User 2022-2032
TABLE 140: GCC Countries Liver Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020
TABLE 141: GCC Countries Liver Cancer Diagnostics Market Value (US$ Mn), By Test Type 2022-2032
TABLE 142: GCC Countries Liver Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020
TABLE 143: GCC Countries Liver Cancer Diagnostics Market Value (US$ Mn), By End User 2022-2032
TABLE 144: South Africa Liver Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020
TABLE 145: South Africa Liver Cancer Diagnostics Market Value (US$ Mn), By Test Type 2022-2032
TABLE 146: South Africa Liver Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020
TABLE 147: South Africa Liver Cancer Diagnostics Market Value (US$ Mn), By End User 2022-2032
TABLE 148: Nigeria Liver Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020
TABLE 149: Nigeria Liver Cancer Diagnostics Market Value (US$ Mn), By Test Type 2022-2032
TABLE 150: Nigeria Liver Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020
TABLE 151: Nigeria Liver Cancer Diagnostics Market Value (US$ Mn), By End User 2022-2032
TABLE 152: Israel Liver Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020
TABLE 153: Israel Liver Cancer Diagnostics Market Value (US$ Mn), By Test Type 2022-2032
TABLE 154: Israel Liver Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020
TABLE 155: Israel Liver Cancer Diagnostics Market Value (US$ Mn), By End User 2022-2032
TABLE 156: Abbott Laboratories Value (US$ Mn), By Test Type 2022-2032
TABLE 157: Abbott Laboratories Value (US$ Mn), By End User 2022-2032
TABLE 158: Agilent Technologies, Inc. Value (US$ Mn), By Test Type 2022-2032
TABLE 159: Agilent Technologies, Inc. Value (US$ Mn), By End User 2022-2032
TABLE 160: Bio Rad Laboratories Inc. Value (US$ Mn), By Test Type 2022-2032
TABLE 161: Bio Rad Laboratories Inc. Value (US$ Mn), By End User 2022-2032
TABLE 162: F. Hoffmann-La Roche Ltd. Value (US$ Mn), By Test Type 2022-2032
TABLE 163: F. Hoffmann-La Roche Ltd. Value (US$ Mn), By End User 2022-2032
TABLE 164: Thermo Fisher Scientific Inc. Value (US$ Mn), By Test Type 2022-2032
TABLE 165: Thermo Fisher Scientific Inc. Value (US$ Mn), By End User 2022-2032
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
List Of Figures
FIG. 01: Global Liver Cancer Diagnostics Market Value (US$ Mn), 2016-2020
FIG. 02: Global Liver Cancer Diagnostics Market Value (US$ Mn) Forecast, 2022-2032
FIG. 03: Global Liver Cancer Diagnostics Market Value (US$ Mn) and Y-o-Y, 2017-2021
FIG. 04: Global AFP Tests Segment Market Value (US$ Mn) By Region, 2016-2020
FIG. 05: Global AFP Tests Segment Market Value (US$ Mn) By Region, 2022-2032
FIG. 06: Global AFP Tests Segment Y-o-Y Growth Rate, By Region, 2017-2021
FIG. 07: Global LFTs Segment Market Value (US$ Mn) By Region, 2016-2020
FIG. 08: Global LFTs Segment Market Value (US$ Mn) By Region, 2022-2032
FIG. 09: Global LFTs Segment Y-o-Y Growth Rate, By Region, 2017-2021
FIG. 10: Global Biopsy Segment Market Value (US$ Mn) By Region, 2016-2020
FIG. 11: Global Biopsy Segment Market Value (US$ Mn) By Region, 2022-2032
FIG. 12: Global Biopsy Segment Y-o-Y Growth Rate, By Region, 2017-2021
FIG. 13: Global Other Segment Market Value (US$ Mn) By Region, 2016-2020
FIG. 14: Global Other Segment Market Value (US$ Mn) By Region, 2022-2032
FIG. 15: Global Other Segment Y-o-Y Growth Rate, By Region, 2017-2021
FIG. 16: Global Hospital Associated Labs Segment Market Value (US$ Mn) By Region, 2016-2020
FIG. 17: Global Hospital Associated Labs Segment Market Value (US$ Mn) By Region, 2022-2032
FIG. 18: Global Hospital Associated Labs Segment Y-o-Y Growth Rate, By Region, 2017-2021
FIG. 19: Global Independent Diagnostic Laboratories Segment Market Value (US$ Mn) By Region, 2016-2020
FIG. 20: Global Independent Diagnostic Laboratories Segment Market Value (US$ Mn) By Region, 2022-2032
FIG. 21: Global Independent Diagnostic Laboratories Segment Y-o-Y Growth Rate, By Region, 2017-2021
FIG. 22: Global Cancer Research Institutes Segment Market Value (US$ Mn) By Region, 2016-2020
FIG. 23: Global Cancer Research Institutes Segment Market Value (US$ Mn) By Region, 2022-2032
FIG. 24: Global Cancer Research Institutes Segment Y-o-Y Growth Rate, By Region, 2017-2021
FIG. 25: Global Others Segment Market Value (US$ Mn) By Region, 2016-2020
FIG. 26: Global Others Segment Market Value (US$ Mn) By Region, 2022-2032
FIG. 27: Global Others Segment Y-o-Y Growth Rate, By Region, 2017-2021
FIG. 28: North America Liver Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020
FIG. 29: North America Liver Cancer Diagnostics Market Value (US$ Mn), By Test Type 2022-2032
FIG. 30: North America Liver Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020
FIG. 31: North America Liver Cancer Diagnostics Market Value (US$ Mn), By End User 2022-2032
FIG. 32: Latin America Liver Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020
FIG. 33: Latin America Liver Cancer Diagnostics Market Value (US$ Mn), By Test Type 2022-2032
FIG. 34: Latin America Liver Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020
FIG. 35: Latin America Liver Cancer Diagnostics Market Value (US$ Mn), By End User 2022-2032
FIG. 36: Europe Liver Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020
FIG. 37: Europe Liver Cancer Diagnostics Market Value (US$ Mn), By Test Type 2022-2032
FIG. 38: Europe Liver Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020
FIG. 39: Europe Liver Cancer Diagnostics Market Value (US$ Mn), By End User 2022-2032
FIG. 40: Japan Liver Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020
FIG. 41: Japan Liver Cancer Diagnostics Market Value (US$ Mn), By Test Type 2022-2032
FIG. 42: Japan Liver Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020
FIG. 43: Japan Liver Cancer Diagnostics Market Value (US$ Mn), By End User 2022-2032
FIG. 44: APEJ Liver Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020
FIG. 45: APEJ Liver Cancer Diagnostics Market Value (US$ Mn), By Test Type 2022-2032
FIG. 46: APEJ Liver Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020
FIG. 47: APEJ Liver Cancer Diagnostics Market Value (US$ Mn), By End User 2022-2032
FIG. 48: MEA Liver Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020
FIG. 49: MEA Liver Cancer Diagnostics Market Value (US$ Mn), By Test Type 2022-2032
FIG. 50: MEA Liver Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020
FIG. 51: MEA Liver Cancer Diagnostics Market Value (US$ Mn), By End User 2022-2032
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
- FAQs -
What is the expected closing market value for Liver Cancer Diagnostics in 2032?
The Liver Cancer Diagnostics landscape is slated to reach a valuation of US$ 26 Billion by 2032.
At what value will the Liver Cancer Diagnostics market close in 2022?
As of 2022, Fact.MR expects the Liver Cancer Diagnostics industry to be valued at US$ 11.73 Billion.
At what percentage will the industry expand during the 2022-2032 period of assessment?
From 2022 to 2032, the Liver Cancer Diagnostics industry is poised to flourish at an 8.2% CAGR.
How will the U.S market for Liver Cancer Diagnostics flourish until 2032?
As per Fact.MR’s projections, the market for Liver Cancer Diagnostics in the U.S will likely expand at a 35% CAGR.
From 2017-2021, what was the documented growth rate for the Liver Cancer Diagnostics market?
According to Fact.MR, a CAGR of 7.8% was recorded for the Liver Cancer Diagnostics market from 2017-2021.
By End-user, which segment is likely to experience the fastest growth rate?
Cancer Research Institute Segment is expected to grow the fastest, at a CAGR of ~8%.
Which is the most preferred Test Type of Liver Cancer Diagnostics?
Based on Test Type, the LFTs for Liver Cancer Diagnostics find their extensive use in the pharmacies segment, documenting an 8.1% value CAGR.
What was the market worth for Liver Cancer Diagnostics in 2021?
As of 2021, the Liver Cancer Diagnostics market was valued at US$ 10.83 Billion.
Liver Cancer Diagnostics Market